Safety and Tolerability of Multimodal Therapy (Ivermectin, Doxycycline, Vitamin C, Vitamin D, and Zinc) With or Without Famotidine in Australian Patients With COVID-19 Infection: A Pilot Cohort Trial
The multimodal therapy for acute COVID-19 was safe and well tolerated. The results justify adequately powered trials of the 5- or 6-component intervention on major early and late outcomes of COVID-19 infections.
Authors
- Karin Ried (ORCID: https://orcid.org/0000-0003-1054-3490)
- Lucas A. McLindon (ORCID: https://orcid.org/0000-0003-2044-8681)
- Bruce Wauchope
- Elizabeth Harradine
- Josie Seman
- Lucia Murnane
Institutions
- The University of Queensland (AU)
- QIMR Berghofer Medical Research Institute (AU)
- Mission Australia (AU)
- Flinders Medical Centre (AU)
- National Institute of Integrative Medicine (AU)
Publication Details
- Journal
- American Journal of Therapeutics
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1097/mjt.0000000000002118
- Primary Topic
- Vitamin D Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00